A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
Q&A: George Church’s Genome Up for Auction
Q&A: George Church’s Genome Up for Auction
A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
Companies are selling reports about a wide range of physical, cognitive, and behavioral traits to consumers based on their genomic data, but such tests have a number of limitations.
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
Assessing mtDNA mutations among healthy people; heritability of intelligence; epigenetic inheritance of maternal malnutrition markers; consumers buy into DNA ancestry
Big ad campaigns and celebrity involvement have helped increase public interest in genetic genealogy, but helping consumers understand their DNA ancestry testing results remains difficult.